: Epicardial adipose tissue surrounds and infiltrates the heart. Epicardial fat displays unique anatomic, genetic, and biomolecular properties. People with obesity and in particular, those with abdominal obesity and associated type 2 diabetes mellitus, have an increased amount of epicardial adipose tissue (EAT). Epicardial fat works well as therapeutic target due to its fast-responding metabolism, organ fat specificity, and easy measurability. Epicardial fat responds to thiazolidinediones (TZD), glucagon-like peptide 1-receptor agonists (GLP1A), sodium-glucose cotransporter 2 inhibitors (SGLT2i), dipeptidyl peptidase-4 inhibitors (DPP4i), and statins. Modulating epicardial fat morphology and genetic profile with targeted pharmacological agents suggests novel strategies in the pharmacotherapy of diabetes and obesity.
Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy / G. Iacobellis, S. Basilico, A.E. Malavazos (HANDBOOK OF EXPERIMENTAL PHARMACOLOGY). - In: From Obesity to Diabetes / [a cura di] J.E. Barrett. - [s.l] : Springer, 2022. [10.1007/164_2021_577]
Targeting Epicardial Fat in Obesity and Diabetes Pharmacotherapy
S. BasilicoPenultimo
;A.E. MalavazosUltimo
2022
Abstract
: Epicardial adipose tissue surrounds and infiltrates the heart. Epicardial fat displays unique anatomic, genetic, and biomolecular properties. People with obesity and in particular, those with abdominal obesity and associated type 2 diabetes mellitus, have an increased amount of epicardial adipose tissue (EAT). Epicardial fat works well as therapeutic target due to its fast-responding metabolism, organ fat specificity, and easy measurability. Epicardial fat responds to thiazolidinediones (TZD), glucagon-like peptide 1-receptor agonists (GLP1A), sodium-glucose cotransporter 2 inhibitors (SGLT2i), dipeptidyl peptidase-4 inhibitors (DPP4i), and statins. Modulating epicardial fat morphology and genetic profile with targeted pharmacological agents suggests novel strategies in the pharmacotherapy of diabetes and obesity.File | Dimensione | Formato | |
---|---|---|---|
Iacobellis2022_Chapter_TargetingEpicardialFatInObesit.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
301.5 kB
Formato
Adobe PDF
|
301.5 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.